P.Glia is dedicated to the development of novel and efficient neural cell isolation technologies and cell based assays for biomarker and drug discovery related to human brain pathology. With its unique MAD-based cell culture technologies and expertise in molecular neurobiology P.Glia provides a highly professional support for neuroscientists, neurologists and pharmaceutical companies with a research focus on CNS trauma and neurodegeneration.
NEW! Since 2016 a new product pipeline of organic natural cosmetics, P.Glia Health & Beauty Biomedical (PG Biomedical), has been established and is currently in further development: Inspired by Nature and supported by our long-term expertise in cell biology
and extracellular matrix research.